These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
638 related items for PubMed ID: 31983023
21. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F, Igwe SC. Cochrane Database Syst Rev; 2017 Feb 14; 2(2):CD003032. PubMed ID: 28195639 [Abstract] [Full Text] [Related]
22. Levetiracetam as add-on therapy in generalised epilepsies. Kumar SP, Smith PE. Seizure; 2004 Oct 14; 13(7):475-7. PubMed ID: 15324824 [Abstract] [Full Text] [Related]
23. Withholding the choice of sodium valproate to young women with generalised epilepsy: Are we causing more harm than good? Mole TB, Appleton R, Marson A. Seizure; 2015 Jan 14; 24():127-30. PubMed ID: 25223837 [Abstract] [Full Text] [Related]
24. Epilepsy treatment in adults and adolescents: Expert opinion, 2016. Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD. Epilepsy Behav; 2017 Apr 14; 69():186-222. PubMed ID: 28237319 [Abstract] [Full Text] [Related]
25. Treatment of typical absence seizures and related epileptic syndromes. Panayiotopoulos CP. Paediatr Drugs; 2001 Apr 14; 3(5):379-403. PubMed ID: 11393330 [Abstract] [Full Text] [Related]
26. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Epileptic Disord; 2004 Dec 14; 6(4):267-70. PubMed ID: 15634623 [Abstract] [Full Text] [Related]
27. Lamotrigine in absence and primary generalized epilepsies. Mikati MA, Holmes GL. J Child Neurol; 1997 Nov 14; 12 Suppl 1():S29-37. PubMed ID: 9429128 [Abstract] [Full Text] [Related]
28. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Tudur Smith C, Marson AG, Williamson PR. Cochrane Database Syst Rev; 2001 Nov 14; (4):CD001769. PubMed ID: 11687121 [Abstract] [Full Text] [Related]
29. Update on pharmacotherapy of myoclonic seizures. Striano P, Belcastro V. Expert Opin Pharmacother; 2017 Feb 14; 18(2):187-193. PubMed ID: 28067060 [Abstract] [Full Text] [Related]
30. Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE). Mostacci B, Ranzato F, Giuliano L, La Neve A, Aguglia U, Bilo L, Durante V, Ermio C, Monti G, Zambrelli E, Lodi MAM, Galimberti CA. Seizure; 2021 Feb 14; 85():26-38. PubMed ID: 33418162 [Abstract] [Full Text] [Related]
31. Levetiracetam in the treatment of idiopathic generalized epilepsies. Grünewald R. Epilepsia; 2005 Feb 14; 46 Suppl 9():154-60. PubMed ID: 16302890 [Abstract] [Full Text] [Related]
35. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Wallace SJ. Epilepsy Res; 1998 Jan 14; 29(2):147-54. PubMed ID: 9477147 [Abstract] [Full Text] [Related]
36. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road. Baheti N, Rathore C, Bansal AR, Shah S, Veedu HK, Prakash S, Kanhere K, Jaiswal SK, Jukkarwala A, Murthy JMK, Radhakrishnan K. Seizure; 2021 Nov 14; 92():112-117. PubMed ID: 34496330 [Abstract] [Full Text] [Related]